Walgreens Boots Alliance Inc (WBA) : Montag Caldwell scooped up 304,068 additional shares in Walgreens Boots Alliance Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 3, 2016. The investment management firm now holds a total of 2,745,978 shares of Walgreens Boots Alliance Inc which is valued at $218,113,033.Walgreens Boots Alliance Inc makes up approximately 4.05% of Montag Caldwell’s portfolio.
Other Hedge Funds, Including , Cambridge Investment Research Advisors boosted its stake in WBA in the latest quarter, The investment management firm added 5,337 additional shares and now holds a total of 48,826 shares of Walgreens Boots Alliance Inc which is valued at $3,878,249. Walgreens Boots Alliance Inc makes up approx 0.09% of Cambridge Investment Research Advisors’s portfolio.Beck Mack Oliver reduced its stake in WBA by selling 900 shares or 7.16% in the most recent quarter. The Hedge Fund company now holds 11,675 shares of WBA which is valued at $925,594. Walgreens Boots Alliance Inc makes up approx 0.03% of Beck Mack Oliver’s portfolio.Cambridge Advisors reduced its stake in WBA by selling 737 shares or 1.51% in the most recent quarter. The Hedge Fund company now holds 47,952 shares of WBA which is valued at $3,801,635. Walgreens Boots Alliance Inc makes up approx 1.76% of Cambridge Advisors’s portfolio.Regentatlantic Capital reduced its stake in WBA by selling 303 shares or 0.68% in the most recent quarter. The Hedge Fund company now holds 44,430 shares of WBA which is valued at $3,560,620. Walgreens Boots Alliance Inc makes up approx 0.35% of Regentatlantic Capital’s portfolio.
Walgreens Boots Alliance Inc opened for trading at $80.97 and hit $81.25 on the upside on Tuesday, eventually ending the session at $80.92, with a gain of 0.04% or 0.03 points. The heightened volatility saw the trading volume jump to 31,97,490 shares. Company has a market cap of $87,413 M.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.31 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 5, 2016. Analyst had a consensus of $1.28. The company had revenue of $30184.00 million for the quarter, compared to analysts expectations of $30666.29 million. The company’s revenue was up 13.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by Barclays on Mar 10, 2016 to “Equal Weight” and Lowered the Price Target to $ 76 from a previous price target of $81 .Mizuho Upgraded Walgreens Boots Alliance Inc on Mar 1, 2016 to ” Buy”, Price Target of the shares are set at $90.
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.